TASE Site - Profile

Advanced Search

Homepage

My TASE

Market Data

Products

Trading & Clearing

Listings

News & Events

Statistics

Publications

Rules & Regulations

About TASE

BIONDVAX PHARMACEUTICALS LTD

Summary

Profile

Charts

Historical Prices

Turnover Statistics

Company Disclosures

www.biondvax.com

Issuer No.

Corporate No.

Market Cap (07/09/2010)

1468

513436105

90,753 NIS thousands

Market Sector

Market Subsector

Indices

INDUSTRY

BIOMED

Biomed Index, Mid Cap TA Index, Tel-Tech Index, TA Composite Index, Additional Indices


Contact Details :
Phone : 08-9302529
Fax : 08-9302531
BABECOFF@BIONDVAX.COM


Controlling Shareholders:

List of Controlling Shareholders

Name	Balance Date	Symbol	Balance	% Capital	% Voting	Market Cap (NIS millions)
Ron Babecoff	03/09/2010	BNDX	5,910,000	16.89	16.89	14.40
Rami Epstein	03/09/2010	BNDX	1,635,000	4.67	4.67	3.90
Moshe Many	06/10/2007	*	54,050	-	-	-
Avner Rotman	13/05/2010	*	190,666	-	-	-
George H. Lowell	13/08/2008	*	200,000	-	-	-

Open in a Separate Window

* Non Tradable

List of Securities

Name	Symbol	ISIN	Issued and Paid-Up Share Capital	Capital Listed for Trading	Market Cap (NIS millions)	% Capital	% Voting
BIONDVAX	BNDX	1105204	35,000,694	35,000,694	85.30	100	100
BIONDVAX W1	BND.W1	1105436	4,936,200	4,936,200	3.70	-	-
BIONDVAX W2	BND.W2	1116615	1,429,789	1,429,789	1.80	-	-
*		1105451	2,237,102	-	-	-	-

Open in a Separate Window

* Non Tradable

Indices

As of 12/09/2010

Name	Symbol	ISIN	Index	Weight (%)	Weight Factor *
BIONDVAX	BNDX	IL0011052045	General	0.01
BIONDVAX	BNDX	IL0011052045	Shares	0.01
BIONDVAX	BNDX	IL0011052045	Industry	0.02
BIONDVAX	BNDX	IL0011052045	Tel-Tech	0.31	1
BIONDVAX	BNDX	IL0011052045	Yeter-Rest of Shares & Convertibles	0.09
BIONDVAX	BNDX	IL0011052045	Yeter-Rest of Shares	0.10
BIONDVAX	BNDX	IL0011052045	Mid Cap TA	0.38	1
BIONDVAX	BNDX	IL0011052045	Biomed	1.41	1
BIONDVAX	BNDX	IL0011052045	TA Composite	0.03	1
BIONDVAX W2	BND.W2	IL0011166159	General	0
BIONDVAX W2	BND.W2	IL0011166159	Warrants	0.13
BIONDVAX W2	BND.W2	IL0011166159	Industry	0
BIONDVAX W2	BND.W2	IL0011166159	Yeter-Rest of Shares & Convertibles	0
BIONDVAX W1	BND.W1	IL0011054363	General	0
BIONDVAX W1	BND.W1	IL0011054363	Warrants	0.28
BIONDVAX W1	BND.W1	IL0011054363	Industry	0
BIONDVAX W1	BND.W1	IL0011054363	Yeter-Rest of Shares & Convertibles	0

Export Table Data

Open in a Separate Window

* Weight factor is calculated for universe indices only

Index Adjusted Data for Company Securities

As of 12/09/2010

Name	Symbol	ISIN	Index Adjusted No. of Shares (IANS) *	Index Adjusted Free Float Class **	Index Adjusted Free Float Rate **	Last IANS Update	Index Adjusted Free Float Market Cap. (NIS millions) **
BIONDVAX	BNDX	IL0011052045	34,702,023	F	80%	01/07/2010	68

Export Table Data

Open in a Separate Window

* IANS - Index Adjusted Number of Shares – listed capital for calculation a security's weight in the index.
For more details, press here.
** Index Adjusted Float Data for calculation of a share's weight in the index, for universe indices.
Free float class is published since 1/7/2010.For more details, press here.

Financial Statements – Key Data (NIS thousands) **

	June 2010 IFRS	June 2009 IFRS	Yearly 2009 IFRS
Balance Sheet
Total Assets	30,175	10,407	33,904
Current Assets	27,338	7,615	31,112
Non Current Assets	2,837	2,792	2,792
Shareholders Equity	29,257	9,734	31,962
Of which Minority Interest	0	0	0
Current Liabilities	887	646	1,914
Long-Term Liabilities	31	27	28
Profit & Loss Statement
Revenues	0	0	0
Gross Profit	0	0	0
Operating Income	-3,071	-1,735	-4,603
Income Before Tax	-2,890	-1,641	-4,576
Net Income	-2,890	-1,641	-4,576
Income Attributable to Shareholders	-2,890	-1,641	-4,576
Earnings per Share	-0.08	-0.06	-0.17
Additional Data
Dividends	0	0	0
Net cash flow generated by operating activities	-5,119	-1,331	-3,350
Financial Ratios
Market to book value	3.10	---	---
Price-Earning Ratio	Loss	---	Loss
Equity-Assets Ratio	97.0 %	93.5 %	94.3 %
Return on Equity	-19.8 %	-33.7 %	-14.3 %

Export Table Data

Note: The financial statements data have been obtained from A-Online and they were compiled and processed by it. The data have not been examined or audited by the Stock Exchange and they are presented as given to the Stock Exchange by A-Online.
The binding data are those appearing in the financial statements published by the Company. Without derogating from the provisions of the use agreement , the Stock Exchange is not liable for any fault, error, mistake or inaccuracy in the data presented. Financial statements published in foreign currency are translated to NIS according to the exchange rate at the date of the financial statements.

Make TASE Your Homepage